All In MedTech

Device Trial Radar · NCT07680543

ProVIDE Studies Post Exit Analysis

Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

25

Planned (sponsor's estimate)

Start

Sep 30, 2026

Primary completion

Jul 31, 2029

Study completion Jul 31, 2029

Sponsor

Lead sponsor
ProVerum MedicalNot on our public-company list
Sponsor type
Industry
First posted
Jul 2, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
Male only, from 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A study to collect data on the post-study exit incidence of secondary reintervention using alternate surgical LUTS therapy.

Conditions

  • BPH With Symptomatic Lower Urinary Tract Symptoms

Interventions

  • ProVee Urethral Expander SystemDevice

    ProVee Expander is placed in prostatic urethra to relieve obstruction due to BPH.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Post-study exit incidence of secondary reintervention using alternate surgical LUTS therapy.Time frame: Up to 36 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Comprehensive Urologic Care

    Lake Barrington, Illinois · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.